The global Rotavirus ELISA Kits market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

Rotavirus ELISA kits are enzyme-linked immunosorbent assay kits used for the detection and quantification of rotavirus antigens in biological samples. These kits utilize the ELISA method to identify the presence of rotavirus, which is a leading cause of gastroenteritis in children and immunocompromised individuals. Rotavirus ELISA kits are crucial tools for diagnosing rotavirus infections, monitoring disease transmission, and evaluating treatment efficacy.

The industry trend for Rotavirus ELISA kits is driven by the increasing incidence of rotavirus infections globally. With a growing emphasis on early detection and treatment of gastroenteritis, there is a growing demand for reliable diagnostic tools like Rotavirus ELISA kits. Additionally, as rotavirus infections pose a significant threat to vulnerable populations, there is a push for rapid and accurate detection methods like Rotavirus ELISA kits that can help mitigate disease burden and improve patient outcomes. The market for Rotavirus ELISA kits is expected to continue expanding as more countries prioritize prevention and control measures against rotavirus infections.

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Rotavirus ELISA Kits market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Scope of Rotavirus ELISA Kits Market Report

Report Metric	Details
Report Name	Rotavirus ELISA Kits Market
Segment by Type	Human Rotavirus ELISA Kits Cow Rotavirus ELISA Kits Mouse Rotavirus ELISA Kits Porcine Rotavirus ELISA Kits Others
Segment by Application	Hospital Laboratory Others
Sales by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	MyBioSource, Novus Biologicals, Abbexa, Eagle Bioscience, Biorbyt, United States Biological, XpressBio, Bioassay Technology Laboratory
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the Rotavirus ELISA Kits study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Rotavirus ELISA Kits Market report?

Ans: The main players in the Rotavirus ELISA Kits Market are MyBioSource, Novus Biologicals, Abbexa, Eagle Bioscience, Biorbyt, United States Biological, XpressBio, Bioassay Technology Laboratory

What are the Application segmentation covered in the Rotavirus ELISA Kits Market report?

Ans: The Applications covered in the Rotavirus ELISA Kits Market report are Hospital, Laboratory, Others

What are the Type segmentation covered in the Rotavirus ELISA Kits Market report?

Ans: The Types covered in the Rotavirus ELISA Kits Market report are Human Rotavirus ELISA Kits, Cow Rotavirus ELISA Kits, Mouse Rotavirus ELISA Kits, Porcine Rotavirus ELISA Kits, Others

1 Study Coverage

1.1 Introduction to Rotavirus ELISA Kits: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Rotavirus ELISA Kits Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Human Rotavirus ELISA Kits

1.2.3 Cow Rotavirus ELISA Kits

1.2.4 Mouse Rotavirus ELISA Kits

1.2.5 Porcine Rotavirus ELISA Kits

1.2.6 Others

1.3 Market Segmentation by Application

1.3.1 Global Rotavirus ELISA Kits Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Laboratory

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Rotavirus ELISA Kits Revenue Estimates and Forecasts 2020-2031

2.2 Global Rotavirus ELISA Kits Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global Rotavirus ELISA Kits Sales Estimates and Forecasts 2020-2031

2.4 Global Rotavirus ELISA Kits Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

3 Competition by Manufacturers

3.1 Global Rotavirus ELISA Kits Sales by Manufacturers

3.1.1 Global Sales Volume by Manufacturers (2020-2025)

3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

3.2 Global Rotavirus ELISA Kits Manufacturer Revenue Rankings and Tiers

3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.3 Manufacturer Profitability Profiles and Pricing Strategies

3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

3.3.2 Manufacturer-Level Price Trends (2020-2025)

3.4 Key Manufacturers Manufacturing Base and Headquarters

3.5 Main Product Type Market Size by Manufacturers

3.5.1 Human Rotavirus ELISA Kits Market Size by Manufacturers

3.5.2 Cow Rotavirus ELISA Kits Market Size by Manufacturers

3.5.3 Mouse Rotavirus ELISA Kits Market Size by Manufacturers

3.5.4 Porcine Rotavirus ELISA Kits Market Size by Manufacturers

3.5.5 Others Market Size by Manufacturers

3.6 Global Rotavirus ELISA Kits Market Concentration and Dynamics

3.6.1 Global Market Concentration (CR5 and HHI)

3.6.2 Entrant/Exit Impact Analysis

3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Global Product Segmentation Analysis

4.1 Global Rotavirus ELISA Kits Sales Performance by Type

4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

4.1.2 Global Sales Market Share by Type (2020-2031)

4.2 Global Rotavirus ELISA Kits Revenue Trends by Type

4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.2.2 Global Revenue Market Share by Type (2020-2031)

4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

4.4 Product Technology Differentiation

4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.5.1 High-Growth Niches and Adoption Drivers

4.5.2 Profitability Hotspots and Cost Drivers

4.5.3 Substitution Threats

5 Global Downstream Application Analysis

5.1 Global Rotavirus ELISA Kits Sales by Application

5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

5.1.2 Global Sales Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Global Rotavirus ELISA Kits Revenue by Application

5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.2.2 Revenue Market Share by Application (2020-2031)

5.3 Global Pricing Dynamics by Application (2020-2031)

5.4 Downstream Customer Analysis

5.4.1 Top Customers by Region

5.4.2 Top Customers by Application

6 North America

6.1 North America Sales Volume and Revenue (2020-2031)

6.2 North America Key Manufacturers Sales Revenue in 2024

6.3 North America Rotavirus ELISA Kits Sales and Revenue by Type (2020-2031)

6.4 North America Rotavirus ELISA Kits Sales and Revenue by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America Rotavirus ELISA Kits Market Size by Country

6.6.1 North America Revenue by Country

6.6.2 North America Sales Trends by Country

6.6.3 US

6.6.4 Canada

6.6.5 Mexico

7 Europe

7.1 Europe Sales Volume and Revenue (2020-2031)

7.2 Europe Key Manufacturers Sales Revenue in 2024

7.3 Europe Rotavirus ELISA Kits Sales and Revenue by Type (2020-2031)

7.4 Europe Rotavirus ELISA Kits Sales and Revenue by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe Rotavirus ELISA Kits Market Size by Country

7.6.1 Europe Revenue by Country

7.6.2 Europe Sales Trends by Country

7.6.3 Germany

7.6.4 France

7.6.5 U.K.

7.6.6 Italy

7.6.7 Russia

8 Asia-Pacific

8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

8.3 Asia-Pacific Rotavirus ELISA Kits Sales and Revenue by Type (2020-2031)

8.4 Asia-Pacific Rotavirus ELISA Kits Sales and Revenue by Application (2020-2031)

8.5 Asia-Pacific Rotavirus ELISA Kits Market Size by Region

8.5.1 Asia-Pacific Revenue by Region

8.5.2 Asia-Pacific Sales Trends by Region

8.6 Asia-Pacific Growth Accelerators and Market Barriers

8.7 Southeast Asia

8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines

8.8 China

8.9 Japan

8.10 South Korea

8.11 China Taiwan

8.12 India

9 Central and South America

9.1 Central and South America Sales Volume and Revenue (2020-2031)

9.2 Central and South America Key Manufacturers Sales Revenue in 2024

9.3 Central and South America Rotavirus ELISA Kits Sales and Revenue by Type (2020-2031)

9.4 Central and South America Rotavirus ELISA Kits Sales and Revenue by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America Rotavirus ELISA Kits Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

10.3 Middle East and Africa Rotavirus ELISA Kits Sales and Revenue by Type (2020-2031)

10.4 Middle East and Africa Rotavirus ELISA Kits Sales and Revenue by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa Rotavirus ELISA Kits Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Turkey

10.6.4 Egypt

10.6.5 South Africa

11 Corporate Profile

11.1 MyBioSource

11.1.1 MyBioSource Corporation Information

11.1.2 MyBioSource Business Overview

11.1.3 MyBioSource Rotavirus ELISA Kits Product Models, Descriptions and Specifications

11.1.4 MyBioSource Rotavirus ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)

11.1.5 MyBioSource Rotavirus ELISA Kits Sales by Product in 2024

11.1.6 MyBioSource Rotavirus ELISA Kits Sales by Application in 2024

11.1.7 MyBioSource Rotavirus ELISA Kits Sales by Geographic Area in 2024

11.1.8 MyBioSource Rotavirus ELISA Kits SWOT Analysis

11.1.9 MyBioSource Recent Developments

11.2 Novus Biologicals

11.2.1 Novus Biologicals Corporation Information

11.2.2 Novus Biologicals Business Overview

11.2.3 Novus Biologicals Rotavirus ELISA Kits Product Models, Descriptions and Specifications

11.2.4 Novus Biologicals Rotavirus ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)

11.2.5 Novus Biologicals Rotavirus ELISA Kits Sales by Product in 2024

11.2.6 Novus Biologicals Rotavirus ELISA Kits Sales by Application in 2024

11.2.7 Novus Biologicals Rotavirus ELISA Kits Sales by Geographic Area in 2024

11.2.8 Novus Biologicals Rotavirus ELISA Kits SWOT Analysis

11.2.9 Novus Biologicals Recent Developments

11.3 Abbexa

11.3.1 Abbexa Corporation Information

11.3.2 Abbexa Business Overview

11.3.3 Abbexa Rotavirus ELISA Kits Product Models, Descriptions and Specifications

11.3.4 Abbexa Rotavirus ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)

11.3.5 Abbexa Rotavirus ELISA Kits Sales by Product in 2024

11.3.6 Abbexa Rotavirus ELISA Kits Sales by Application in 2024

11.3.7 Abbexa Rotavirus ELISA Kits Sales by Geographic Area in 2024

11.3.8 Abbexa Rotavirus ELISA Kits SWOT Analysis

11.3.9 Abbexa Recent Developments

11.4 Eagle Bioscience

11.4.1 Eagle Bioscience Corporation Information

11.4.2 Eagle Bioscience Business Overview

11.4.3 Eagle Bioscience Rotavirus ELISA Kits Product Models, Descriptions and Specifications

11.4.4 Eagle Bioscience Rotavirus ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)

11.4.5 Eagle Bioscience Rotavirus ELISA Kits Sales by Product in 2024

11.4.6 Eagle Bioscience Rotavirus ELISA Kits Sales by Application in 2024

11.4.7 Eagle Bioscience Rotavirus ELISA Kits Sales by Geographic Area in 2024

11.4.8 Eagle Bioscience Rotavirus ELISA Kits SWOT Analysis

11.4.9 Eagle Bioscience Recent Developments

11.5 Biorbyt

11.5.1 Biorbyt Corporation Information

11.5.2 Biorbyt Business Overview

11.5.3 Biorbyt Rotavirus ELISA Kits Product Models, Descriptions and Specifications

11.5.4 Biorbyt Rotavirus ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)

11.5.5 Biorbyt Rotavirus ELISA Kits Sales by Product in 2024

11.5.6 Biorbyt Rotavirus ELISA Kits Sales by Application in 2024

11.5.7 Biorbyt Rotavirus ELISA Kits Sales by Geographic Area in 2024

11.5.8 Biorbyt Rotavirus ELISA Kits SWOT Analysis

11.5.9 Biorbyt Recent Developments

11.6 United States Biological

11.6.1 United States Biological Corporation Information

11.6.2 United States Biological Business Overview

11.6.3 United States Biological Rotavirus ELISA Kits Product Models, Descriptions and Specifications

11.6.4 United States Biological Rotavirus ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)

11.6.5 United States Biological Recent Developments

11.7 XpressBio

11.7.1 XpressBio Corporation Information

11.7.2 XpressBio Business Overview

11.7.3 XpressBio Rotavirus ELISA Kits Product Models, Descriptions and Specifications

11.7.4 XpressBio Rotavirus ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)

11.7.5 XpressBio Recent Developments

11.8 Bioassay Technology Laboratory

11.8.1 Bioassay Technology Laboratory Corporation Information

11.8.2 Bioassay Technology Laboratory Business Overview

11.8.3 Bioassay Technology Laboratory Rotavirus ELISA Kits Product Models, Descriptions and Specifications

11.8.4 Bioassay Technology Laboratory Rotavirus ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)

11.8.5 Bioassay Technology Laboratory Recent Developments

12 Value Chain and Supply-Chain Analysis

12.1 Rotavirus ELISA Kits Industry Chain

12.2 Rotavirus ELISA Kits Upstream Materials Analysis

12.2.1 Raw Materials

12.2.2 Key Suppliers Market Share & Risk Assessment

12.3 Rotavirus ELISA Kits Integrated Production Analysis

12.3.1 Manufacturing Footprint Analysis

12.3.2 Regional Production Market Share (2020-2031)

12.3.3 Regulatory and Trade Policy Impact on Production

12.3.4 Production Technology Overview

12.3.5 Regional Cost Drivers

12.4 Rotavirus ELISA Kits Sales Channels and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

13 Rotavirus ELISA Kits Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global Rotavirus ELISA Kits Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

FEATURED COMPANIES

United States Biological

XpressBio

Bioassay Technology Laboratory

List of Tables

Table 1. Global Rotavirus ELISA Kits Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Rotavirus ELISA Kits Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Rotavirus ELISA Kits Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Rotavirus ELISA Kits Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Rotavirus ELISA Kits Revenue by Region (2026-2031) & (US$ Million)

Table 6. Global Rotavirus ELISA Kits Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)

Table 7. Global Rotavirus ELISA Kits Sales by Region (2020-2025) & (K Units)

Table 8. Global Rotavirus ELISA Kits Sales by Region (2026-2031) & (K Units)

Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 10. Global Rotavirus ELISA Kits Sales by Manufacturers (2020-2025) & (K Units)

Table 11. Global Rotavirus ELISA Kits Sales Share by Manufacturers (2020-2025)

Table 12. Global Rotavirus ELISA Kits Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 13. Global Rotavirus ELISA Kits Revenue Market Share by Manufacturers (2020-2025)

Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 15. Global Rotavirus ELISA Kits by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rotavirus ELISA Kits as of 2024)

Table 16. Global Rotavirus ELISA Kits Average Gross Margin (%) by Manufacturer (2020 VS 2024)

Table 17. Global Rotavirus ELISA Kits Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)

Table 18. Key Manufacturers Rotavirus ELISA Kits Manufacturing Base and Headquarters

Table 19. Global Rotavirus ELISA Kits Market Concentration Ratio (CR5 and HHI)

Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 22. Global Rotavirus ELISA Kits Sales by Type (2020-2025) & (K Units)

Table 23. Global Rotavirus ELISA Kits Sales by Type (2026-2031) & (K Units)

Table 24. Global Rotavirus ELISA Kits Revenue by Type (2020-2025) & (US$ Million)

Table 25. Global Rotavirus ELISA Kits Revenue by Type (2026-2031) & (US$ Million)

Table 26. Global Rotavirus ELISA Kits ASP by Type (2020-2031) & (US$/Unit)

Table 27. Technical Specifications by Key Product Type

Table 28. Global Rotavirus ELISA Kits Sales by Application (2020-2025) & (K Units)

Table 29. Global Rotavirus ELISA Kits Sales by Application (2026-2031) & (K Units)

Table 30. Rotavirus ELISA Kits High-Growth Sectors Demand CAGR (2024-2031)

Table 31. Global Rotavirus ELISA Kits Revenue by Application (2020-2025) & (US$ Million)

Table 32. Global Rotavirus ELISA Kits Revenue by Application (2026-2031) & (US$ Million)

Table 33. Global Rotavirus ELISA Kits ASP by Application (2020-2031) & (US$/Unit)

Table 34. Top Customers by Region

Table 35. Top Customers by Application

Table 36. North America Rotavirus ELISA Kits Growth Accelerators and Market Barriers

Table 37. North America Rotavirus ELISA Kits Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 38. North America Rotavirus ELISA Kits Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 39. Europe Rotavirus ELISA Kits Growth Accelerators and Market Barriers

Table 40. Europe Rotavirus ELISA Kits Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Europe Rotavirus ELISA Kits Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 42. Asia-Pacific Rotavirus ELISA Kits Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 43. Asia-Pacific Rotavirus ELISA Kits Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 44. Asia-Pacific Rotavirus ELISA Kits Growth Accelerators and Market Barriers

Table 45. Southeast Asia Rotavirus ELISA Kits Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Central and South America Rotavirus ELISA Kits Investment Opportunities and Key Challenges

Table 47. Central and South America Rotavirus ELISA Kits Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 48. Middle East and Africa Rotavirus ELISA Kits Investment Opportunities and Key Challenges

Table 49. Middle East and Africa Rotavirus ELISA Kits Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 50. MyBioSource Corporation Information

Table 51. MyBioSource Description and Major Businesses

Table 52. MyBioSource Product Models, Descriptions and Specifications

Table 53. MyBioSource Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 54. MyBioSource Sales Value Proportion by Product in 2024

Table 55. MyBioSource Sales Value Proportion by Application in 2024

Table 56. MyBioSource Sales Value Proportion by Geographic Area in 2024

Table 57. MyBioSource Rotavirus ELISA Kits SWOT Analysis

Table 58. MyBioSource Recent Developments

Table 59. Novus Biologicals Corporation Information

Table 60. Novus Biologicals Description and Major Businesses

Table 61. Novus Biologicals Product Models, Descriptions and Specifications

Table 62. Novus Biologicals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 63. Novus Biologicals Sales Value Proportion by Product in 2024

Table 64. Novus Biologicals Sales Value Proportion by Application in 2024

Table 65. Novus Biologicals Sales Value Proportion by Geographic Area in 2024

Table 66. Novus Biologicals Rotavirus ELISA Kits SWOT Analysis

Table 67. Novus Biologicals Recent Developments

Table 68. Abbexa Corporation Information

Table 69. Abbexa Description and Major Businesses

Table 70. Abbexa Product Models, Descriptions and Specifications

Table 71. Abbexa Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 72. Abbexa Sales Value Proportion by Product in 2024

Table 73. Abbexa Sales Value Proportion by Application in 2024

Table 74. Abbexa Sales Value Proportion by Geographic Area in 2024

Table 75. Abbexa Rotavirus ELISA Kits SWOT Analysis

Table 76. Abbexa Recent Developments

Table 77. Eagle Bioscience Corporation Information

Table 78. Eagle Bioscience Description and Major Businesses

Table 79. Eagle Bioscience Product Models, Descriptions and Specifications

Table 80. Eagle Bioscience Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 81. Eagle Bioscience Sales Value Proportion by Product in 2024

Table 82. Eagle Bioscience Sales Value Proportion by Application in 2024

Table 83. Eagle Bioscience Sales Value Proportion by Geographic Area in 2024

Table 84. Eagle Bioscience Rotavirus ELISA Kits SWOT Analysis

Table 85. Eagle Bioscience Recent Developments

Table 86. Biorbyt Corporation Information

Table 87. Biorbyt Description and Major Businesses

Table 88. Biorbyt Product Models, Descriptions and Specifications

Table 89. Biorbyt Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 90. Biorbyt Sales Value Proportion by Product in 2024

Table 91. Biorbyt Sales Value Proportion by Application in 2024

Table 92. Biorbyt Sales Value Proportion by Geographic Area in 2024

Table 93. Biorbyt Rotavirus ELISA Kits SWOT Analysis

Table 94. Biorbyt Recent Developments

Table 95. United States Biological Corporation Information

Table 96. United States Biological Description and Major Businesses

Table 97. United States Biological Product Models, Descriptions and Specifications

Table 98. United States Biological Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 99. United States Biological Recent Developments

Table 100. XpressBio Corporation Information

Table 101. XpressBio Description and Major Businesses

Table 102. XpressBio Product Models, Descriptions and Specifications

Table 103. XpressBio Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 104. XpressBio Recent Developments

Table 105. Bioassay Technology Laboratory Corporation Information

Table 106. Bioassay Technology Laboratory Description and Major Businesses

Table 107. Bioassay Technology Laboratory Product Models, Descriptions and Specifications

Table 108. Bioassay Technology Laboratory Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 109. Bioassay Technology Laboratory Recent Developments

Table 110. Key Raw Materials Distribution

Table 111. Raw Materials Key Suppliers

Table 112. Critical Raw Material Supplier Concentration (2024) & Risk Index

Table 113. Milestones in Production Technology Evolution

Table 114. Distributors List

Table 115. Market Trends and Market Evolution

Table 116. Market Drivers and Opportunities

Table 117. Market Challenges, Risks, and Restraints

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

List of Figures

Figure 1. Rotavirus ELISA Kits Product Picture

Figure 2. Global Rotavirus ELISA Kits Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Human Rotavirus ELISA Kits Product Picture

Figure 4. Cow Rotavirus ELISA Kits Product Picture

Figure 5. Mouse Rotavirus ELISA Kits Product Picture

Figure 6. Porcine Rotavirus ELISA Kits Product Picture

Figure 7. Others Product Picture

Figure 8. Global Rotavirus ELISA Kits Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 9. Hospital

Figure 10. Laboratory

Figure 11. Others

Figure 12. Rotavirus ELISA Kits Report Years Considered

Figure 13. Global Rotavirus ELISA Kits Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Rotavirus ELISA Kits Revenue (2020-2031) & (US$ Million)

Figure 15. Global Rotavirus ELISA Kits Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 16. Global Rotavirus ELISA Kits Revenue Market Share by Region (2020-2031)

Figure 17. Global Rotavirus ELISA Kits Sales (2020-2031) & (K Units)

Figure 18. Global Rotavirus ELISA Kits Sales (CAGR) by Region (2020-2031) (K Units)

Figure 19. Global Rotavirus ELISA Kits Sales Market Share by Region (2020-2031)

Figure 20. Top 5 and Top 10 Manufacturers Rotavirus ELISA Kits Sales Volume Market Share in 2024

Figure 21. Global Rotavirus ELISA Kits Revenue Market Share Ranking (2024)

Figure 22. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 23. Human Rotavirus ELISA Kits Revenue Market Share by Manufacturer in 2024

Figure 24. Cow Rotavirus ELISA Kits Revenue Market Share by Manufacturer in 2024

Figure 25. Mouse Rotavirus ELISA Kits Revenue Market Share by Manufacturer in 2024

Figure 26. Porcine Rotavirus ELISA Kits Revenue Market Share by Manufacturer in 2024

Figure 27. Others Revenue Market Share by Manufacturer in 2024

Figure 28. Global Rotavirus ELISA Kits Sales Market Share by Type (2020-2031)

Figure 29. Global Rotavirus ELISA Kits Revenue Market Share by Type (2020-2031)

Figure 30. Global Rotavirus ELISA Kits Sales Market Share by Application (2020-2031)

Figure 31. Global Rotavirus ELISA Kits Revenue Market Share by Application (2020-2031)

Figure 32. North America Rotavirus ELISA Kits Sales YoY (2020-2031) & (K Units)

Figure 33. North America Rotavirus ELISA Kits Revenue YoY (2020-2031) & (US$ Million)

Figure 34. North America Top 5 Manufacturers Rotavirus ELISA Kits Sales Revenue (US$ Million) in 2024

Figure 35. North America Rotavirus ELISA Kits Sales Volume (K Units) by Type (2020- 2031)

Figure 36. North America Rotavirus ELISA Kits Sales Revenue (US$ Million) by Type (2020 - 2031)

Figure 37. North America Rotavirus ELISA Kits Sales Volume (K Units) by Application (2020-2031)

Figure 38. North America Rotavirus ELISA Kits Sales Revenue (US$ Million) by Application (2020-2031)

Figure 39. US Rotavirus ELISA Kits Revenue (2020-2031) & (US$ Million)

Figure 40. Canada Rotavirus ELISA Kits Revenue (2020-2031) & (US$ Million)

Figure 41. Mexico Rotavirus ELISA Kits Revenue (2020-2031) & (US$ Million)

Figure 42. Europe Rotavirus ELISA Kits Sales YoY (2020-2031) & (K Units)

Figure 43. Europe Rotavirus ELISA Kits Revenue YoY (2020-2031) & (US$ Million)

Figure 44. Europe Top 5 Manufacturers Rotavirus ELISA Kits Sales Revenue (US$ Million) in 2024

Figure 45. Europe Rotavirus ELISA Kits Sales Volume (K Units) by Type (2020-2031)

Figure 46. Europe Rotavirus ELISA Kits Sales Revenue (US$ Million) by Type (2020-2031)

Figure 47. Europe Rotavirus ELISA Kits Sales Volume (K Units) by Application (2020-2031)

Figure 48. Europe Rotavirus ELISA Kits Sales Revenue (US$ Million) by Application (2020-2031)

Figure 49. Germany Rotavirus ELISA Kits Revenue (2020-2031) & (US$ Million)

Figure 50. France Rotavirus ELISA Kits Revenue (2020-2031) & (US$ Million)

Figure 51. U.K. Rotavirus ELISA Kits Revenue (2020-2031) & (US$ Million)

Figure 52. Italy Rotavirus ELISA Kits Revenue (2020-2031) & (US$ Million)

Figure 53. Russia Rotavirus ELISA Kits Revenue (2020-2031) & (US$ Million)

Figure 54. Asia-Pacific Rotavirus ELISA Kits Sales YoY (2020-2031) & (K Units)

Figure 55. Asia-Pacific Rotavirus ELISA Kits Revenue YoY (2020-2031) & (US$ Million)

Figure 56. Asia-Pacific Top 8 Manufacturers Rotavirus ELISA Kits Sales Revenue (US$ Million) in 2024

Figure 57. Asia-Pacific Rotavirus ELISA Kits Sales Volume (K Units) by Type (2020- 2031)

Figure 58. Asia-Pacific Rotavirus ELISA Kits Sales Revenue (US$ Million) by Type (2020- 2031)

Figure 59. Asia-Pacific Rotavirus ELISA Kits Sales Volume (K Units) by Application (2020-2031)

Figure 60. Asia-Pacific Rotavirus ELISA Kits Sales Revenue (US$ Million) by Application (2020-2031)

Figure 61. Indonesia Rotavirus ELISA Kits Revenue (2020-2031) & (US$ Million)

Figure 62. Japan Rotavirus ELISA Kits Revenue (2020-2031) & (US$ Million)

Figure 63. South Korea Rotavirus ELISA Kits Revenue (2020-2031) & (US$ Million)

Figure 64. China Taiwan Rotavirus ELISA Kits Revenue (2020-2031) & (US$ Million)

Figure 65. India Rotavirus ELISA Kits Revenue (2020-2031) & (US$ Million)

Figure 66. Central and South America Rotavirus ELISA Kits Sales YoY (2020-2031) & (K Units)

Figure 67. Central and South America Rotavirus ELISA Kits Revenue YoY (2020-2031) & (US$ Million)

Figure 68. Central and South America Top 5 Manufacturers Rotavirus ELISA Kits Sales Revenue (US$ Million) in 2024

Figure 69. Central and South America Rotavirus ELISA Kits Sales Volume (K Units) by Type (2021-2031)

Figure 70. Central and South America Rotavirus ELISA Kits Sales Revenue (US$ Million) by Type (2020-2031)

Figure 71. Central and South America Rotavirus ELISA Kits Sales Volume (K Units) by Application (2020-2031)

Figure 72. Central and South America Rotavirus ELISA Kits Sales Revenue (US$ Million) by Application (2020-2031)

Figure 73. Brazil Rotavirus ELISA Kits Revenue (2020-2025) & (US$ Million)

Figure 74. Argentina Rotavirus ELISA Kits Revenue (2020-2025) & (US$ Million)

Figure 75. Middle East, and Africa Rotavirus ELISA Kits Sales YoY (2020-2031) & (K Units)

Figure 76. Middle East and Africa Rotavirus ELISA Kits Revenue YoY (2020-2031) & (US$ Million)

Figure 77. Middle East and Africa Top 5 Manufacturers Rotavirus ELISA Kits Sales Revenue (US$ Million) in 2024

Figure 78. Middle East and Africa Rotavirus ELISA Kits Sales Volume (K Units) by Type (2021-2031)

Figure 79. South America Rotavirus ELISA Kits Sales Revenue (US$ Million) by Type (2020-2031)

Figure 80. Middle East and Africa Rotavirus ELISA Kits Sales Volume (K Units) by Application (2020-2031)

Figure 81. Middle East and Africa Rotavirus ELISA Kits Sales Revenue (US$ Million) by Application (2020-2031)

Figure 82. GCC Countries Rotavirus ELISA Kits Revenue (2020-2025) & (US$ Million)

Figure 83. Turkey Rotavirus ELISA Kits Revenue (2020-2025) & (US$ Million)

Figure 84. Egypt Rotavirus ELISA Kits Revenue (2020-2025) & (US$ Million)

Figure 85. South Africa Rotavirus ELISA Kits Revenue (2020-2025) & (US$ Million)

Figure 86. Rotavirus ELISA Kits Industry Chain Mapping

Figure 87. Regional Rotavirus ELISA Kits Manufacturing Base Distribution (%)

Figure 88. Global Rotavirus ELISA Kits Production Market Share by Region (2020-2031)

Figure 89. Rotavirus ELISA Kits Production Process

Figure 90. Regional Rotavirus ELISA Kits Production Cost Structure

Figure 91. Channels of Distribution (Direct Vs Distribution)

Figure 92. Bottom-up and Top-down Approaches for This Report

Figure 93. Data Triangulation

Figure 94. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions